Stephen Duane Oetgen bought $700K of Arxis (ARXS)

Executed Apr 17, disclosed Apr 21, 3 days later.

Value, as filed

$700K

25,000 sh × $28.00

Executed

Apr 17

the trade date, as filed

Disclosed

Apr 21

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

-10.4%

-8.2% from execution

Over the 21 trading sessions from the disclosed entry session (Apr 20), the stock returned -10.4% (delay-adjusted); from the execution session (Apr 17), -8.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer

SO Stephen Duane Oetgen Director profile →

Stephen Duane Oetgen (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in ARXS. Across 1 priced purchase filing, the average 21-session return was -8.2% from execution and -10.4% from disclosure (delay-adjusted; derived). The largest single filing was $700K of ARXS (25,000 sh × $28.00, as filed), executed Apr 17.

The name

ARXS ARXS ARXS · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→